Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

A bowl of oats a day: could it boost calcium in pregnancy?

NCT ID NCT07751198

Disease control Sponsor: University of Lahore Hospital (ULH) Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 07, 2026 · Last updated Aug 13, 2026 · Updated 2 times

Summary

This trial tests whether eating oat-based porridge daily, alongside standard prenatal calcium and vitamin D supplements, can improve calcium and vitamin D levels in pregnant women with mild to moderate hypocalcemia. Researchers will measure blood levels at weeks 8 and 33 of pregnancy and track outcomes like fetal growth and preeclampsia. The goal is to see if this simple dietary addition offers extra nutritional support for healthier pregnancies.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Oat-based porridge (dietary supplement) alongside standard calcium and vitamin D3 supplements
What this could lead to
If effective, daily oat porridge could offer a simple, affordable way to support calcium and vitamin D levels in pregnant women with hypocalcemia, potentially reducing risks like preeclampsia and poor fetal growth.
What could go wrong
This is an early-stage trial with a modest number of participants, and results may not apply to all pregnant women. The porridge is a supplement, not a replacement for medical care, and its benefits beyond standard supplements remain uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

192 people

The number who actually took part.

Started

Aug 2024

Finished

Feb 2025

Lead sponsor

A research network

The lead sponsor is a research network or cooperative group.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

20 to 40 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Already taking vitamin D and calcium supplements as prescribed by the doctor. * Pregnant women in their 2nd and 3rd trimester. * Women between 20 to 40 years of age will be included. * Women with mild to moderate hypocalcemia (serum calcium less than 8-8.6 mg/dl) and 25(OH)D less than 30ng/ml will be entered to study. Exclusion Criteria: * Women having twin pregnancy. * Gestational diabetes or diabetes before pregnancy. * Chronic hypertension. * Fetal anomaly, oligohydramnios or polyhydramnios, parathyroid disorders, hepatic or renal diseases, malnutrition. * Use of anti-convulsive and immunosuppressive drugs.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hypocalcemia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

autosomal dominant hypocalcemia disease Hypocalcemia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Hypocalcemia Pregnancy complications affecting fetus (diagnosis)

Contacts and locations

Locations

  • Saira Memorial Hospital Model Town Lahore Pakistan

    Lahore, Punjab Province, 54700, Pakistan

More trials for these conditions

Other studies related to the condition(s) this trial covers.